🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IIIb/IV, open label, multicentre study of efalizumab (anti ...
Status
Completed
Location
Medical Information
Start Date
2004-12-13
Trial ID
NCT00249808
Treatments Being Tested
Islet transplantation in type 1 diabetics with hypoglycemic unawareness usi...
Status
Completed
Location
Emory University
Start Date
2005-12
Trial ID
NCT00276250
Treatments Being Tested
The purpose of this study is to investigate the efficacy of Raptiva (efaliz...
Status
Withdrawn
Location
Cleveland Clinic
Start Date
2006-03
Trial ID
NCT00308204
Treatments Being Tested
Efalizumab is an immunosuppressive recombinant humanized IgG1 monocolonal a...
Status
Withdrawn
Location
Vitreous Retina Macula Consultants of New York
Start Date
2008-03
Trial ID
NCT00726466
Treatments Being Tested
This is a pilot investigational study of the appropriate therapeutic regime...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT01079988
The toxicity of calcineurin inhibitors(CNI)is a major factor limiting the s...
Status
Terminated
Location
Emory University
Start Date
2007-05
Trial ID
NCT00472082
Treatments Being Tested
The purpose of this study is to demonstrate a measurable improvement on a v...
Status
Completed
Location
UMDNJ Psoriasis Center of Excellence
Start Date
2005-03
Trial ID
NCT00146003
Treatments Being Tested
The purpose of Biobadaderm is a to study the safety of systemic therapy in ...
Status
Unknown
Location
Hospital Universitari German Trias y Pujol.
Start Date
2008-10
Trial ID
NCT02075697
This is a Phase IIIb, randomized, double-blind, parallel-group, placebo-con...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00109317
Treatments Being Tested
This is a Phase IIIb, open label, uncontrolled, multicenter study designed ...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00338143
Treatments Being Tested